Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Clin J Am Soc Nephrol ; 13(4): 551-559, 2018 04 06.
Artigo em Inglês | MEDLINE | ID: mdl-29545381

RESUMO

BACKGROUND AND OBJECTIVES: Incidence of ESKD is three times higher in black Americans than in whites, and CKD prevalence continues to rise among black Americans. Community-based kidney disease screening may increase early identification and awareness of black Americans at risk, but it is challenging to implement. This study aimed to identify participants' perspectives of community kidney disease screening. The Health Belief Model provides a theoretic framework for conceptualization of these perspectives and optimization of community kidney disease screening activities. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Researchers in collaboration with the Tennessee Kidney Foundation conducted three focus groups of adults in black American churches in Nashville, Tennessee. Questions examined views on CKD information, access to care, and priorities of kidney disease health. Content analysis was used. Guided by the Health Belief Model, a priori themes were generated, and additional themes were derived from the data using an inductive approach. RESULTS: Thirty-two black Americans completed the study in 2014. Participants were mostly women (79%) with a mean age of 56 years old (range, 24-78). Two major categories of barriers to kidney disease screening were identified: (1) participant factors, including limited kidney disease knowledge, spiritual/religious beliefs, emotions, and culture of the individual; and (2) logistic factors, including lack of convenience and incentives and poor advertisement. Potential facilitators of CKD screening included provision of CKD education, convenience of screening activities, and use of culturally sensitive and enhanced communication strategies. Program recommendations included partnering with trusted community members, selecting convenient locations, tailored advertising, and provision of compensation. CONCLUSIONS: Findings of this study suggest that provider-delivered culturally sensitive education and stakeholder engagement are critical to increase trust, decrease fear, and maximize participation and early identification of kidney disease among black Americans considering community screening.


Assuntos
Negro ou Afro-Americano , Serviços de Saúde Comunitária , Conhecimentos, Atitudes e Prática em Saúde/etnologia , Nefropatias/diagnóstico , Adulto , Publicidade , Negro ou Afro-Americano/psicologia , Idoso , Competência Cultural , Emoções , Feminino , Grupos Focais , Educação em Saúde , Acessibilidade aos Serviços de Saúde , Humanos , Nefropatias/economia , Nefropatias/etnologia , Masculino , Pessoa de Meia-Idade , Motivação , Religião , Confiança , Adulto Jovem
2.
Am J Nephrol ; 34(1): 64-70, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21677428

RESUMO

BACKGROUND/AIMS: Percutaneous kidney biopsy (PKB) is the primary diagnostic tool for kidney disease. Outpatient 'day surgery' (ODS) following PKB in low-risk patients has previously been described as a safe alternative to inpatient observation (IO). This study aims to determine if ODS is less costly compared to IO while accounting for all institutional costs (IC) associated with post-PKB complications, including death. METHODS: A cost minimization study was performed using decision analysis methodology which models relative costs in relation to outcome probabilities yielding an optimum decision. The potential outcomes included major complications (bleeding requiring blood transfusion or advanced intervention), minor complications (bleeding or pain requiring additional observation), and death. Probabilities were obtained from the published literature and a base case was selected. IC were obtained for all complications from institutional activity-based cost estimates. The base case assumed a complication rate of 10% with major bleeding occurring in 2.5% of patients (for both arms) and death in 0.1 and 0.15% of IO and ODS patients, respectively. RESULTS: ODS costs USD 1,394 per biopsy compared to USD 1,800 for IO inclusive of all complications. IC for ODS remain less when overall complications <20%, major complications <5.5%, and IC per death

Assuntos
Assistência Ambulatorial/economia , Biópsia por Agulha/economia , Hospitalização/economia , Nefropatias/patologia , Rim/patologia , Hemorragia Pós-Operatória/economia , Biópsia por Agulha/efeitos adversos , Biópsia por Agulha/mortalidade , Transfusão de Sangue/economia , Controle de Custos , Custos Hospitalares , Humanos , Responsabilidade Legal/economia , Hemorragia Pós-Operatória/etiologia , Probabilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA